Sign in to view content

Biosimilar Paradox: How Biosimilar Use Will Increase Patient and Healthcare Costs

Ravi Parikh, MD MPH

Video
Published 2023

Related

Retinal Nonperfusion on Widefield OCTA in Determining Diabetic Retinopathy Severity
Annual Meeting Talks
2023
Retinal Nonperfusion and Anti-VEGF Therapy in Diabetic Retinopathy: What We Know and What We Don’t Know
Dante Joseph Pieramici, MD
Updates from the Field
2017
Impact and Outcomes of Anti-VEGF Prior Authorization Requests: Insights From a Large Database Analysis
Saira Khanna, MD
Annual Meeting Talks
2023

Category: Socioeconomics

See more